Roseburia intestinalis-derived extracellular vesicles alleviate osteoporosis through gut microbiota-regulated histidylleucine via Akt/FOXO1 signaling
{"Osteoporosis":[0],"(OP),":[1],"characterized":[2,94],"by":[3,23,44,86],"reduced":[4],"bone":[5,42,109,160],"mass":[6],"and":[7,14,27,48,81,93,105,127,139,149,158,172],"microarchitectural":[8],"deterioration,":[9],"significantly":[10],"impairs":[11],"patient":[12],"health":[13],"quality":[15],"of":[16,69,107,125,130,181],"life.":[17],"Conventional":[18],"therapies":[19],"are":[20],"often":[21],"limited":[22],"long-term":[24],"safety":[25],"concerns":[26],"adverse":[28],"effects.":[29],"Recent":[30],"studies":[31],"suggest":[32],"that":[33],"extracellular":[34],"vesicles":[35],"(EVs)":[36],"play":[37],"a":[38,55,66,191],"critical":[39],"role":[40],"in":[41,77,115,153,163,176],"remodeling":[43],"promoting":[45],"osteoblast":[46],"differentiation":[47,104,138],"mineralization":[49,106,140],"while":[50],"inhibiting":[51],"osteoclast":[52],"activity,":[53],"offering":[54],"potential":[56,170],"therapeutic":[57,169,193],"avenue":[58],"for":[59,195],"OP.":[60,196],"In":[61],"this":[62],"study,":[63],"we":[64],"observed":[65],"significant":[67],"reduction":[68],"Roseburia":[70],"intestinalis":[71],"(R.intestinalis),":[72],"an":[73],"anaerobic,":[74],"gram-positive":[75],"bacterium,":[76],"both":[78,147],"OP":[79,177],"patients":[80],"ovariectomized":[82],"(OVX)":[83],"model":[84],"rats":[85],"16S":[87],"rRNA":[88],"sequencing.":[89],"We":[90],"successfully":[91],"isolated":[92],"R.intestinalis-derived":[95],"EVs":[96],"(REVs),":[97],"which":[98,185],"were":[99,119,151],"found":[100],"to":[101,121,135],"promote":[102,136],"the":[103,123,128,142,168,182],"human":[108],"marrow":[110],"mesenchymal":[111],"stromal":[112],"cells":[113],"(hBMSCs)":[114],"vitro.":[116],"Mechanistically,":[117],"REVs":[118,148,171],"shown":[120],"enhance":[122],"production":[124],"histidylleucine,":[126],"administration":[129],"histidylleucine":[131,150,175,189],"alone":[132],"was":[133],"sufficient":[134],"hBMSCs":[137],"through":[141,179],"Akt/FOXO1":[143],"signaling":[144],"pathway.":[145],"Furthermore,":[146],"effective":[152],"reversing":[154],"gut":[155],"microbiota":[156],"dysbiosis":[157],"improving":[159],"mineral":[161],"density":[162],"vivo.":[164],"These":[165],"findings":[166],"highlight":[167],"their":[173],"metabolite":[174],"treatment":[178],"modulation":[180],"\\"gut-bone\\"":[183],"axis,":[184],"providing":[186],"insights":[187],"into":[188],"as":[190],"promising":[192],"agent":[194]}
Authors
- Shukai Yang
- Sheng Yu (ORCID: https://orcid.org/0000-0003-3837-8060)
- Peng Li (ORCID: https://orcid.org/0000-0003-1795-6466)
- Liu Y (ORCID: https://orcid.org/0000-0002-0994-0109)
- Jiaxu Lu
- Jiaxian Chen (ORCID: https://orcid.org/0000-0002-6592-5173)
- J Chen
- Jiaqi Chu
- Chengshuo Huang
- Hao Lin
- Jianhao Li
Institutions
- Guangdong Medical College (CN)
- Cell Technology (China) (CN)
- Affiliated Hospital of Guangdong Medical College Hospital (CN)
Publication Details
- Journal
- Communications Biology
- Published
- 2026-06-01
- DOI
- https://doi.org/10.1038/s42003-026-10401-x
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China